Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP:RTGN)

5.020 UNCHANGED
Last Price Updated: 3:07 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.020
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 5.020
Today's Range 5.020 - 5.020
52wk Range 1.600 - 6.360
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
Company to use facility to further development of RetinalGenix’s therapies for neurodegenerative and retinal diseases 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGenix Technologies to Participate at the 37th Annual Roth Conference
Company will discuss its patented remote monitoring high-resolution retinal imaging system RetinalCam™ and associated biomarker technologies 
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire

Performance

YTD
-21.1%
-21.1%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+213.7%
+213.7%
1 Year
+213.7%
+213.7%

More News

Read More
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
Retinalgenix Technologies, Inc. Expands Team to Hasten the Launch of DNA/GPS
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire
Vinay Mehindru, MD, MBA Appointed to RetinalGenix Technologies Inc. Board of Directors
From RetinalGeniX Technologies, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is RTGN publicly traded?
Yes, RTGN is publicly traded.
What exchange does RTGN trade on?
RTGN trades on the OTC Traded
What is the ticker symbol for RTGN?
The ticker symbol for RTGN is RTGN on the OTC Traded
What is the current price of RTGN?
The current price of RTGN is 5.020
When was RTGN last traded?
The last trade of RTGN was at 04/03/25 03:07 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.